Sports / Entertainment

Two-Year Data from Phase 2 Trial of Genzyme’s Eliglustat Tartrate for Gaucher Disease To Be Published in the Journal …
CAMBRIDGE, Mass.—-Genzyme Corporation announced today that the two-year follow-up results from the phase 2 clinical trial of its investigational therapy known as eliglustat tartrate have been accepted for publication in the journal Blood.

Read more on Business Wire via Yahoo! Finance

COR-BMOD trial results of Contrave published in Obesity
Orexigen Therapeutics, Inc. announced the online publication of results from its COR-BMOD trial of Contrave (naltrexone SR/bupropion SR) in the journal Obesity. The COR-BMOD trial evaluated intensive behavior modification plus Contrave32 (32mg naltrexone sustained release (SR)/360mg bupropion SR) compared to BMOD plus placebo, in 793 overweight or obese patients.

Read more on News-Medical-Net

Advaxis Gets Formal Go-Ahead from India’s DCGI to Conduct Phase II Cervical Cancer Trial
NORTH BRUNSWICK, N.J.—-Advaxis, Inc., , the live, attenuated Listeria monocytogenes immunotherapy company, has received formal permission from the Drugs Controller General India to conduct a Phase II clinical trial of ADXS11-001, the Company’s flagship drug construct, among 110 women with advanced, metastatic cervical cancer that has progressed subsequent to treatment with cytotoxic therapy …

Read more on Business Wire via Yahoo! Finance

Oncolytics Biotech receives Canadian approval for combination REOLYSIN Phase 3 trial in head, neck cancer
Oncolytics Biotech Inc. today announced that it has received a No Objection Letter from Health Canada to conduct its Phase 3 trial examining REOLYSIN in combination with paclitaxel and carboplatin in patients with platinum-refractory head and neck cancers.

Read more on News-Medical-Net

Product Description
This digital document is an article from San Diego Business Journal, published by CBJ, L.P. on April 5, 2010. The length of the article is 685 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Big Pharma Co. floats trial balloon for bio incubator: Johnson & Johnson plans to host fledgling biotech companies at its La Jolla research facility.(BIOTECH)
Author: Heather Chambers
Publication: San Diego Business Journal (Magazine/Journal)
Date: April 5, 2010
Publisher: CBJ, L.P.
Volume: 31 Issue: 14 Page: 3(2)

Distributed by Gale, a part of Cengage Learning

Big Pharma Co. floats trial balloon for bio incubator: Johnson & Johnson plans to host fledgling biotech companies at its La Jolla research facility.: … An article from: San Diego Business Journal

Product Description
This digital document is an article from San Diego Business Journal, published by CBJ, L.P. on April 5, 2010. The length of the article is 685 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Big Pharma Co. floats trial balloon for bio incubator: Johnson & Johnson plans to host fledgling biotech companies at its La Jolla research facility.(BIOTECH)
Author: Heather Chambers
Publication: San Diego Business Journal (Magazine/Journal)
Date: April 5, 2010
Publisher: CBJ, L.P.
Volume: 31 Issue: 14 Page: 3(2)

Distributed by Gale, a part of Cengage Learning

Big Pharma Co. floats trial balloon for bio incubator: Johnson & Johnson plans to host fledgling biotech companies at its La Jolla research facility.: … An article from: San Diego Business Journal

Product Description
This digital document is an article from San Diego Business Journal, published by CBJ, L.P. on April 5, 2010. The length of the article is 685 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Big Pharma Co. floats trial balloon for bio incubator: Johnson & Johnson plans to host fledgling biotech companies at its La Jolla research facility.(BIOTECH)
Author: Heather Chambers
Publication: San Diego Business Journal (Magazine/Journal)
Date: April 5, 2010
Publisher: CBJ, L.P.
Volume: 31 Issue: 14 Page: 3(2)

Distributed by Gale, a part of Cengage Learning

Big Pharma Co. floats trial balloon for bio incubator: Johnson & Johnson plans to host fledgling biotech companies at its La Jolla research facility.: … An article from: San Diego Business Journal

Product Description
This digital document is an article from San Diego Business Journal, published by CBJ, L.P. on April 5, 2010. The length of the article is 685 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Big Pharma Co. floats trial balloon for bio incubator: Johnson & Johnson plans to host fledgling biotech companies at its La Jolla research facility.(BIOTECH)
Author: Heather Chambers
Publication: San Diego Business Journal (Magazine/Journal)
Date: April 5, 2010
Publisher: CBJ, L.P.
Volume: 31 Issue: 14 Page: 3(2)

Distributed by Gale, a part of Cengage Learning

Big Pharma Co. floats trial balloon for bio incubator: Johnson & Johnson plans to host fledgling biotech companies at its La Jolla research facility.: … An article from: San Diego Business Journal

Product Description
This digital document is an article from San Diego Business Journal, published by CBJ, L.P. on April 5, 2010. The length of the article is 685 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Big Pharma Co. floats trial balloon for bio incubator: Johnson & Johnson plans to host fledgling biotech companies at its La Jolla research facility.(BIOTECH)
Author: Heather Chambers
Publication: San Diego Business Journal (Magazine/Journal)
Date: April 5, 2010
Publisher: CBJ, L.P.
Volume: 31 Issue: 14 Page: 3(2)

Distributed by Gale, a part of Cengage Learning

Big Pharma Co. floats trial balloon for bio incubator: Johnson & Johnson plans to host fledgling biotech companies at its La Jolla research facility.: … An article from: San Diego Business Journal

Product Description
This digital document is an article from San Diego Business Journal, published by CBJ, L.P. on April 5, 2010. The length of the article is 685 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Big Pharma Co. floats trial balloon for bio incubator: Johnson & Johnson plans to host fledgling biotech companies at its La Jolla research facility.(BIOTECH)
Author: Heather Chambers
Publication: San Diego Business Journal (Magazine/Journal)
Date: April 5, 2010
Publisher: CBJ, L.P.
Volume: 31 Issue: 14 Page: 3(2)

Distributed by Gale, a part of Cengage Learning

Big Pharma Co. floats trial balloon for bio incubator: Johnson & Johnson plans to host fledgling biotech companies at its La Jolla research facility.: … An article from: San Diego Business Journal